From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 513.00
-35.00 (-6.39%)
At close: Jul 16, 2026
From Bio Co.,Ltd Revenue
From Bio Co.,Ltd had revenue of 19.17B KRW in the quarter ending March 31, 2026, with 3.62% growth. This brings the company's revenue in the last twelve months to 72.83B, up 9.92% year-over-year. In the year 2025, From Bio Co.,Ltd had annual revenue of 72.16B with 7.41% growth.
Revenue (ttm)
72.83B
Revenue Growth
+9.92%
P/S Ratio
0.20
Revenue / Employee
520.23M
Employees
140
Market Cap
14.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.16B | 4.98B | 7.41% |
| Dec 31, 2024 | 67.18B | 457.90M | 0.69% |
| Dec 31, 2023 | 66.72B | -32.61B | -32.83% |
| Dec 31, 2022 | 99.33B | -35.77B | -26.48% |
| Dec 31, 2021 | 135.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ICH Co., Ltd. | 46.96B |
| NGeneBio | 31.20B |
| Billions | 25.31B |
| BECU AI | 17.04B |
| Barunson Entertainment & Arts | 9.47B |
| E8 Co.,Ltd. | 1.29B |